• Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

BB Biotech AG

+ Add to Watchlist

BION:SW

180.7000 CHF 0.3000 0.17%

As of 03:29:07 ET on 10/21/2014.

Snapshot for BB Biotech AG (BION)

Open: 180.2000 High - Low: 180.8000 - 179.6000 Primary Exchange: SIX Swiss Ex
Volume: 5,875 52-Week Range: 124.1300 - 187.1000 Beta vs NBI: 0.8029

ETF Chart for BION

No chart data available.
  • BION:SW 180.7000
  • 1D
  • 1M
  • 1Y
181.0000
Interactive BION Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BION

BB Biotech AG is an investment company. The Company invests in biotech companies that operate in areas that include oncology, cardiovascular diseases, infectious diseases and autoimmune diseases.

Inception Date: 1993-11-16 Telephone: Tel: +41 44 267 67 00
Managers: DANIEL KOLLER
Web Site: www.bbbiotech.ch

Fundamentals for BION

NAV (on 2014-10-17) 235.3000
Assets (M) (on 2002-12-31) 1,579.0000
Shares out (M) 11.85
Market Cap (M) 2,144.85
% Premium -27.11
Average 52-Week % Premium -21.6667
Fund Leveraged N

Dividends for BION

Dividend Type Return of Capital
Dividend Frequency Annual
Last Dividend Net (on 2014-03-21) 7.0000
Dividend Yield (ttm) 3.87%

Performance for BION

1-Month +1.69% 1-Year +46.03%
3-Month +17.46% 3-Year +53.89%
Year To Date +34.31% 5-Year +23.09%
Expense Ratio 1.69

Top Fund Holdings for BION

Filing Date: 06/30/2014
Name Position Value % of Total
Celgene Corp 4,219,298 321,400,000 12.783%
Actelion Ltd 2,496,886 280,200,000 11.144%
Gilead Sciences Inc 3,488,496 256,600,000 10.205%
Incyte Corp 4,163,790 208,500,000 8.292%
Isis Pharmaceuticals Inc 6,706,526 205,000,000 8.153%
Vertex Pharmaceuticals Inc 1,404,445 118,000,000 4.693%
Medivation Inc 1,499,706 102,500,000 4.077%
Alexion Pharmaceuticals Inc 727,428 100,800,000 4.009%
Novo Nordisk A/S 2,258,770 92,200,000 3.667%
Synageva BioPharma Corp 898,476 83,500,000 3.321%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil